Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Proton Radiotherapy and Capecitabine for Unresectable Pancreatic Cancer
NCT02598349Phase 2Recruiting
- Sponsor
- Proton Collaborative Group
- Start
- Apr 2016
- Primary completion
- Oct 2039
- Countries
- 1
01
Overview
A Phase 2 trial of capecitabine in pancreatic cancer (PC), sponsored by Proton Collaborative Group. Started Apr 2016; status: recruiting.
02
Drugs
capecitabine
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT02598349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02598349.